Mono Vaccine Market by Type and Geography - Forecast and Analysis 2022-2026

Published: Oct 2022 Pages: 127 SKU: IRTNTR74519

The global mono vaccine market size is estimated to grow by USD 2.8 billion between 2021 to  2026 accelerating at a CAGR of 5.16%. 

This mono vaccine market report extensively covers market segmentation by Type (meningococcal vaccine, japanese encephalitis vaccine, hepatitis vaccine, yellow fever vaccine, and others) and Geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. 

Factors such as the increase in pediatric populations, initiatives taken by government agencies, recent drug development, and innovations in the market are propelling the growth of the market.

Mono Vaccine Market Overview:

 View the Bestselling Market Research Sample 

Mono Vaccine Market Covid Recovery Analysis:

The COVID-19 pandemic severely affected North American countries in 2020, disrupting the supply chain and manufacturing units of mono vaccines due to lockdowns. Pharmaceutical companies focused on developing COVID-19 vaccines and OTC drugs, reducing the production volume of mono vaccines. This had a negative impact on the market in 2020. However, the region's large-scale vaccination drive and investment in the pharmaceutical sector resumed operations in 2021, leading to expected growth in the regional mono vaccine market during the forecast period.

Mono Vaccine Market: Key Drivers, Trends, Challenges

 Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Mono Vaccine Market Driver

The rise in the number of newborn infants has led to a higher demand for combination vaccines for immunization, especially in developed countries with an increasing population of children due to immigration. However, developing regions such as India and China have a rapidly growing population due to low income, limited awareness of birth control, and improper implementation of birth control programs. The administration of human combination vaccines is recommended by the national health regulatory authority of each country to provide immunity against fatal diseases for infants and children. The prevalence of viral infections is high in developing nations, leading to an increased demand for human combination vaccines, driving the growth of the market during the forecast period.

Significant Mono Vaccine Market Trends

The mono vaccine market is experiencing more mergers and acquisitions between companies to develop and sell drugs for infectious disease treatment. Market players are targeting fast-growing markets like India, Brazil, China, and South Africa, and to stay ahead, they are implementing M&A strategies to expand their product range and enhance their market position. Some recent examples of M and A are mentioned below:

  • In August 2021, Sanofi acquired Translate Bio, a clinical-stage mRNA therapeutics company, for over USD 3 billion. With this acquisition, the company aims to increase the application of messenger RNA (mRNA) for the development of therapeutics and vaccines.
  • In May 2020, Novavax, a biotechnology company specializing in next-generation vaccines, spent over USD 160 million and acquired Praha Vaccines. The acquisition involves a biologics manufacturing facility and other manufacturing assets located in Bohumil, the Czech Republic.

Therefore, the rise in merger and acquisition activities across the globe is expected to boost market growth during the forecast period.

Major Mono Vaccine Market Challenge

Developing vaccines is challenging due to sophisticated pathogen invasion mechanisms and limited understanding of specific immune responses, which can hinder the development process. Rapid pathogen phenotypic changes pose a major challenge, and lengthy clinical trials increase vaccine costs. Vaccines require proper storage conditions and a temperature-controlled supply chain to maintain efficacy. However, human error and equipment malfunctions can cause vaccine deterioration, particularly in resource-limited countries where storage guidelines are not followed. This hinders the growth of the market in focus during the forecast period.

Who are the Major Mono Vaccine Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

En.biokangtai- The company, Shenzhen Kangtai Biological Products Co. Ltd. offers a mono vaccine, namely the SARS-COV 2 Vaccine.

The report also includes detailed analyses of the competitive landscape of the market and information about prominent and key market vendors, including:

  • AstraZeneca Plc
  • Aurobindo Pharma Ltd.
  • Bavarian Nordic AS
  • China National Pharmaceutical Group Corp.
  • Dynavax Technologies Corp.
  • GlaxoSmithKline Plc
  • Johnson and Johnson
  • Merck and Co. Inc.
  • Moderna Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co. Ltd.
  • Valneva SE
  • VBI Vaccines Inc.

Technavio’s report consists of a holistic analysis of the key development Analysis,  development stage, key market players, their marketing strategies, and powerful innovations to help any client gain a competitive edge.  

Mono Vaccine Market Segmentation by Type, Geography

Type Analysis

The mono vaccine market share growth in the Meningococcal Vaccine segment will be significant during the forecast period. Meningococcal meningitis is a type of meningitis caused by the Neisseria meningitidis bacteria, which can be transmitted from an infected person through direct contact with droplets from the throat or respiratory secretions. Asymptomatic carriers are also capable of transmitting the infection. Such prevalence of the meningococcal disease across the globe is expected to fuel the growth of the global mono vaccine market during the forecast period.

To gain further insights on the market contribution of various segments View Sample PDF 

Geographical Analysis

For more insights on the market share of various regions View PDF Sample now!

36% of the market’s growth will originate from North America during the forecast period. US, Germany, UK, France, and China are the key markets for mono vaccine market in North America. Market growth in this region will be slower than the growth in regions.

The increase in the pediatric population will facilitate the mono vaccine market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

 

Mono Vaccine Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 5.16%

Market growth 2022-2026

USD 2.8 billion

Market structure

Concentrated

YoY growth (%)

4.2

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 36%

Key consumer countries

US, Germany, UK, France, and China

Competitive landscape

Leading companies, Competitive Strategies, Consumer engagement scope

Key companies profiled

AstraZeneca Plc, Aurobindo Pharma Ltd., Bavarian Nordic AS, China National Pharmaceutical Group Corp., Dynavax Technologies Corp., GlaxoSmithKline Plc, Johnson and Johnson, Merck and Co. Inc., Moderna Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Valneva SE, and VBI Vaccines Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF sample

What are the Key Data Covered in this Mono Vaccine Market Research Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive mono vaccine market growth during the next five years
  • Precise estimation of the mono vaccine market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the mono vaccine market industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of mono vaccine market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Type

    • 5.1 Market segments
      • Exhibit 24: Chart on Type - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
    • 5.2 Comparison by Type
      • Exhibit 26: Chart on Comparison by Type
      • Exhibit 27: Data Table on Comparison by Type
    • 5.3 Meningococcal Vaccine - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Meningococcal Vaccine - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Meningococcal Vaccine - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Meningococcal Vaccine - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Meningococcal Vaccine - Year-over-year growth 2021-2026 (%)
    • 5.4 Japanese Encephalitis Vaccine - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Japanese Encephalitis Vaccine - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Japanese Encephalitis Vaccine - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Japanese Encephalitis Vaccine - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Japanese Encephalitis Vaccine - Year-over-year growth 2021-2026 (%)
    • 5.5 Hepatitis Vaccine - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Hepatitis Vaccine - Market size and forecast 2021-2026 ($ million)
      • Exhibit 37: Data Table on Hepatitis Vaccine - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Chart on Hepatitis Vaccine - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Hepatitis Vaccine - Year-over-year growth 2021-2026 (%)
    • 5.6 Yellow Fever Vaccine - Market size and forecast 2021-2026
      • Exhibit 40: Chart on Yellow Fever Vaccine - Market size and forecast 2021-2026 ($ million)
      • Exhibit 41: Data Table on Yellow Fever Vaccine - Market size and forecast 2021-2026 ($ million)
      • Exhibit 42: Chart on Yellow Fever Vaccine - Year-over-year growth 2021-2026 (%)
      • Exhibit 43: Data Table on Yellow Fever Vaccine - Year-over-year growth 2021-2026 (%)
    • 5.7 Others - Market size and forecast 2021-2026
      • Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
      • Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
    • 5.8 Market opportunity by Type
      • Exhibit 48: Market opportunity by Type ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 50: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 51: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 52: Chart on Geographic comparison
      • Exhibit 53: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 UK - Market size and forecast 2021-2026
      • Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.10 France - Market size and forecast 2021-2026
      • Exhibit 82: Chart on France - Market size and forecast 2021-2026 ($ million)
      • Exhibit 83: Data Table on France - Market size and forecast 2021-2026 ($ million)
      • Exhibit 84: Chart on France - Year-over-year growth 2021-2026 (%)
      • Exhibit 85: Data Table on France - Year-over-year growth 2021-2026 (%)
    • 7.11 China - Market size and forecast 2021-2026
      • Exhibit 86: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 87: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 88: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 89: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 90: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 91: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 93: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 94: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 95: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 96: Matrix on vendor position and classification
            • 10.3 AstraZeneca Plc
              • Exhibit 97: AstraZeneca Plc - Overview
              • Exhibit 98: AstraZeneca Plc - Product / Service
              • Exhibit 99: AstraZeneca Plc - Key news
              • Exhibit 100: AstraZeneca Plc - Key offerings
            • 10.4 China National Pharmaceutical Group Corp.
              • Exhibit 101: China National Pharmaceutical Group Corp. - Overview
              • Exhibit 102: China National Pharmaceutical Group Corp. - Product / Service
              • Exhibit 103: China National Pharmaceutical Group Corp. - Key offerings
            • 10.5 Dynavax Technologies Corp.
              • Exhibit 104: Dynavax Technologies Corp. - Overview
              • Exhibit 105: Dynavax Technologies Corp. - Product / Service
              • Exhibit 106: Dynavax Technologies Corp. - Key news
              • Exhibit 107: Dynavax Technologies Corp. - Key offerings
            • 10.6 GlaxoSmithKline Plc
              • Exhibit 108: GlaxoSmithKline Plc - Overview
              • Exhibit 109: GlaxoSmithKline Plc - Business segments
              • Exhibit 110: GlaxoSmithKline Plc - Key offerings
              • Exhibit 111: GlaxoSmithKline Plc - Segment focus
            • 10.7 Merck and Co. Inc.
              • Exhibit 112: Merck and Co. Inc. - Overview
              • Exhibit 113: Merck and Co. Inc. - Business segments
              • Exhibit 114: Merck and Co. Inc. - Key news
              • Exhibit 115: Merck and Co. Inc. - Key offerings
              • Exhibit 116: Merck and Co. Inc. - Segment focus
            • 10.8 Moderna Inc.
              • Exhibit 117: Moderna Inc. - Overview
              • Exhibit 118: Moderna Inc. - Business segments
              • Exhibit 119: Moderna Inc. - Key offerings
              • Exhibit 120: Moderna Inc. - Segment focus
            • 10.9 Pfizer Inc.
              • Exhibit 121: Pfizer Inc. - Overview
              • Exhibit 122: Pfizer Inc. - Product / Service
              • Exhibit 123: Pfizer Inc. - Key news
              • Exhibit 124: Pfizer Inc. - Key offerings
            • 10.10 Sanofi SA
              • Exhibit 125: Sanofi SA - Overview
              • Exhibit 126: Sanofi SA - Business segments
              • Exhibit 127: Sanofi SA - Key news
              • Exhibit 128: Sanofi SA - Key offerings
              • Exhibit 129: Sanofi SA - Segment focus
            • 10.11 Serum Institute of India Pvt. Ltd.
              • Exhibit 130: Serum Institute of India Pvt. Ltd. - Overview
              • Exhibit 131: Serum Institute of India Pvt. Ltd. - Product / Service
              • Exhibit 132: Serum Institute of India Pvt. Ltd. - Key offerings
            • 10.12 Shenzhen Kangtai Biological Products Co. Ltd.
              • Exhibit 133: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
              • Exhibit 134: Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
              • Exhibit 135: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 136: Inclusions checklist
                • Exhibit 137: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 138: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 139: Research methodology
                • Exhibit 140: Validation techniques employed for market sizing
                • Exhibit 141: Information sources
              • 11.5 List of abbreviations
                • Exhibit 142: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              mono vaccine market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis